Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions

Clinical trial NCT05536037 · TERMINATED

Trial details

NCT number: NCT05536037
Sponsor: Thomas Jefferson University
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Erythroplakia Leukoplakia Oral Cavity Carcinoma Proliferative Verrucous Leukoplakia

Start date: 2022-05-04
Primary completion: 2024-03-16
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.